Antibody Engineering & Therapeutics Europe – Pioneering the Future of Antibody-Based Medicines is Europe’s foremost conference and exhibition dedicated to next-generation therapeutic antibodies. Serving as the European counterpart to the prestigious U.S.-based Antibody Engineering & Therapeutics, the event brings together leading scientists, clinicians, and industry professionals to explore the latest advances in antibody research, development, and clinical application. Organized annually by Informa Connect, a division of Informa PLC known for delivering high-level knowledge-driven events, the conference rotates among Europe’s premier centers of scientific research and innovation, providing participants with an ideal environment for networking, collaboration, and insight into cutting-edge therapeutic solutions.Driving innovation across the antibody value chainThe program is designed to address the entire spectrum of antibody therapeutics, from early discovery to clinical translation and commercial implementation. Attendees gain access to a wealth of specialized topics, including:Discovery of novel targets and innovative selection techniquesAdvanced binding formats, bispecific and multispecific antibodies, and non-IgG constructsAntibody-drug conjugates (ADCs) and novel payload strategiesAI and machine learning applications for therapeutic design and optimizationThis comprehensive focus ensures that participants can explore both the scientific foundations and practical applications of next-generation antibody therapies, gaining insights into emerging trends that are shaping the biopharmaceutical landscape.Translating research into clinical impactA central objective of Antibody Engineering & Therapeutics Europe is bridging the gap between preclinical research and clinical implementation. The conference emphasizes strategies for:Translating laboratory discoveries into therapeutic candidatesManufacturing and formulation of complex biological agentsExploring therapeutic opportunities beyond oncology, including immunology, neurology, and autoimmune diseasesBy highlighting these translational processes, the event supports professionals in navigating the challenges of moving innovative antibody candidates from bench to bedside, ensuring that scientific breakthroughs have real-world impact.Cutting-edge technologies and methodologiesThe conference also serves as a platform for showcasing state-of-the-art technologies that drive innovation in antibody therapeutics. Topics and presentations often cover:High-throughput screening and selection platformsComputational modeling and AI-driven optimization of antibody candidatesAdvanced bioanalytical techniques and characterization methodsNovel delivery systems and formulation strategies for enhanced efficacyRegulatory considerations and best practices in clinical developmentThese sessions provide attendees with actionable knowledge that can improve research efficiency, accelerate drug development timelines, and optimize therapeutic outcomes.Networking and interdisciplinary collaborationAntibody Engineering & Therapeutics Europe thrives on its ability to bring together experts from diverse sectors, including academia, biotechnology, pharmaceutical companies, and regulatory agencies. The conference offers multiple avenues for professional interaction: panel discussions, roundtables, poster sessions, and dedicated networking events. These opportunities foster collaborations that span discovery, development, and commercialization, helping to translate scientific innovation into tangible therapeutic solutions.Shaping the future of biopharmaceutical innovationUltimately, the conference is more than a meeting it is a strategic hub for knowledge exchange, professional growth, and industry advancement. Participants leave with:Insights into cutting-edge antibody research and developmentExposure to novel technologies and AI-driven methodologiesConnections with leading experts and potential collaboratorsPractical guidance for translating scientific discoveries into clinical therapiesBy covering the full spectrum of antibody engineering, therapeutic development, and clinical translation, Antibody Engineering & Therapeutics Europe plays an indispensable role in shaping the next generation of biopharmaceutical innovation in Europe and beyond. It is a must-attend event for anyone involved in the discovery, development, and application of antibody-based therapies.
